Article

Ten-Year Outcomes of Medical Cannabis for Chronic Low Back Pain: Opioid Reduction, Pain Relief, and Functional Improvement in 1,000 Patients

2026-02-18

Abstract excerpt

<title>Abstract</title> <p>Purpose To evaluate 10-year outcomes of medical cannabis therapy on opioid use, pain intensity, functional disability, concomitant medication use, and adverse events in cannabis-naïve chronic low back pain (CLBP) patients, with particular attention to clinically meaningful outcomes defined by established minimal clinically important difference (MCID) thresholds. Methods Single-center...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 31d388b4-ff66-512b-b7d1-a681748e4e71
DOI: 10.21203/rs.3.rs-8584281/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Ten-Year Outcomes of Medical Cannabis for Chronic Low Back Pain: Opioid Reduction, Pain Relief, and Functional Improvement in 1,000 PatientsDOI 10.21203/rs.3.rs-8584281/v1Read

Weed Out the Risk: Pharmacovigilance in Medical Cannabis UsersSemantic proximity Read

A large Australian longitudinal cohort registry demonstrates sustained safety and efficacy of oral medicinal cannabis for at least two yearsSemantic proximity Read

Chronic Pain, Cannabis Legalization and Cannabis Use Disorder in Veterans Health Administration Patients, 2005 to 2019Semantic proximity Read

Cannabis use is associated with pain severity and interference among cancer survivorsSemantic proximity Read

Exploring Novel Pharmacotherapy Candidates for Cannabis Use Disorder: Uncovering Promising Agents on the Horizon by Mechanism of ActionSemantic proximity Read

Pharmacogenetic association study of cannabis use in chronic painSemantic proximity Read

Identifying high-risk comorbidities of short and long-term opioid prescription useSemantic proximity Read

Epidemiology of chronic pain and opioid use in primary care – a scoping review of big data researchSemantic proximity Read

Changes in the Incidence of Cannabis-Related Disorders after the Cannabis Act and the COVID-19 Pandemic in Québec, CanadaSemantic proximity Read

Higher average potency across the United States is associated with progression to first cannabis use disorder symptomSemantic proximity Read

Global and regional burden of four drug use disorders in the elderly, 1990 to 2021: an analysis of the Global Burden of Disease StudySemantic proximity Read

Pharmacological Smoking Cessation Interventions in People with Cannabis, Opioid, or Stimulant Use Disorders: A Systematic ReviewSemantic proximity Read